Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy

IMPORTANCE: Immune-related adverse events (irAEs) due to immune checkpoint blockade (ICB) have been shown to be positively associated with survival. Among patients with metastatic melanoma, evidence supporting this association has been conflicting, while ipilimumab-nivolumab combination ICB has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, Alexander S., Goutam, Siddhartha, Stukalin, Igor, Ewanchuk, Benjamin W., Sander, Michael, Meyers, Daniel E., Pabani, Aliyah, Cheung, Winson Y., Heng, Daniel Y. C., Cheng, Tina, Monzon, Jose G., Navani, Vishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856439/
https://www.ncbi.nlm.nih.gov/pubmed/36480204
http://dx.doi.org/10.1001/jamanetworkopen.2022.45596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856439/
https://www.ncbi.nlm.nih.gov/pubmed/36480204
http://dx.doi.org/10.1001/jamanetworkopen.2022.45596

Ejemplares similares